Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 研究・開発
  • タンパク質解析
  • イムノアッセイ
  • HTRF
  • HTRF Thalidomide Red Ligand

HTRF Thalidomide Red Ligand

Generic Vial HTRF
Video Play Button
HTRF Thalidomide Red Ligand
Generic Vial HTRF
Video Play Button
Generic Vial HTRF
Generic Vial HTRF
Generic Vial HTRF
Generic Vial HTRF
Video Play Button

HTRF Thalidomide-Red ligand is a derivative of Thalidomide and can be used as a fluorescent tracer for HTRF Thalidomide-Red ligand binding assays, associated with the HTRF Cereblon Binding kit to investigate cooperativity effects within PROTAC drug discovery.

View product information

HTRF Thalidomide-Red ligand is a derivative of Thalidomide and can be used as a fluorescent tracer for HTRF Thalidomide-Red ligand binding assays, associated with the HTRF Cereblon Binding kit to investigate cooperativity effects within PROTAC drug discovery.

View product information
Product variant
Unit Size: 1 unit
Part #:
64BDCRBNRED
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
Request more information
Generic Vial HTRF
Generic Vial HTRF
Video Play Button
HTRF Thalidomide Red Ligand
Generic Vial HTRF
Video Play Button
Generic Vial HTRF
Generic Vial HTRF
HTRF Thalidomide Red Ligand
Generic Vial HTRF
Generic Vial HTRF
Video Play Button
Quick links
  • Video
  • Product information
  • Resources
  • SDS, COAs, manuals and more
  • Related products
  • Recently viewed
  • Get help

Product information

  • Overview
  • How it works
  • Assay details
  • Assay validation
  • Specifications
  • Video gallery

Overview

HTRF Thalidomide-Red ligand is primarily intended to perform affinity binding curves to Cereblon protein using HTRF® technology.

Cereblon, also known as CRBN, is involved in many biological processes and is closely associated with proliferation, apoptosis, cell metabolism, and the occurrence of many diseases. Cereblon is also one of the two most popular E3 ligases which is recruited by bifunctional Proteolysis-targeting chimeras (PROTACs) to induce ubiquitination and subsequent proteasomal degradation of a targeted protein. Cereblon interacts with several proteins to form the functional E3 ubiquitin ligase complex, in which CRBN functions as a substrate receptor of the E3 ubiquitin ligase complex and targets proteins for proteolysis.

HTRF Thalidomide-Red ligand binding assays can be used in association with the HTRF Cereblon binding kit (#64BDCRBNPEG/H) for cooperativity binding studies in order to monitor the effect of PROTAC protein substrate on the Kd of HTRF Thalidomide-Red ligand for Cereblon protein, enabling accurate analysis of cooperative effect monitored with the HTRF Cereblon binding kit.

How it works

HTRF Thalidomide-Red ligand binding assay principle on cereblon protein

HTRF Thalidomide-Red ligand binding is detected in a direct binding assay format using an anti GST-Europium Cryptate antibody which binds to Human Cereblon WT GST-tagged. When the dyes are in close proximity, the excitation of the donor with a light source (laser or flash lamp) triggers a Fluorescence Resonance Energy Transfer (FRET) towards the acceptor, which in turn fluoresces at a specific wavelength (665 nm) (Image A). The specific binding signal is calculated by subtracting the non-specific binding signal from the total signal, enabling determination of Kd for HTRF Thalidomide-Red ligand (Image B).

1ppi-how-it-works-assay-principle-htrf-thalidomide-red-ligand-1_.svg
2ppi-how-it-works-assay-principle-htrf-thalidomide-red-ligand-2.svg

 

HTRF Thalidomide-Red ligand binding assay protocol

Saturation binding experiments of HTRF Thalidomide-Red ligand can be run in 384-well plates by dispensing 5µL of Diluent 9 buffer (for Total binding) or Cereblon binding standard (for non specific binding). Then 5µL of PROTAC binding buffer 1 (for reference) or PROTAC protein substrate diluted in PROTAC buffer 1 (for cooperativity studies) are added, followed by 5µL of GST-CRBN protein. Finally, 5µL of a pre-mixed solution of HTRF Thalidomide-Red ligand and Anti-GST Eu cryptate antibody are added. The HTRF ratio is measured after 3 hours of incubation at room temperature.

The HTRF Ratio is measured after 2 hours of incubation at room temperature.

 

3ppi-how-it-works-assay-protocol-htrf-thalidomide-red-ligand.svg

Assay details

HTRF Thalidomide-Red ligand Kd (reference without PROTAC protein substrate) 3.2nM ±0.8 (SD)

Assay validation

Example of cooperativity binding studies with HTRF Thalidomide-Red ligand

,Example of cooperativity binding studies with HTRF Thalidomide-Red ligand to monitor the effect of a PROTAC protein substrate as model tested at 100nM, on the Kd of HTRF Thalidomide-Red ligand with GST-CRBN protein in the same conditions as the PROTAC compound screening assays performed with the HTRF CRBN binding kit. Results from this example show no effect of this PROTAC protein substrate on the Kd of HTRF Thalidomide-Red ligand. 

4assay-validation-htrf-thalidomide-red-ligand.svg

 

Specifications

Automation Compatible
Yes
Brand
HTRF
Detection Modality
HTRF
Product Group
Fluorescent Reagent
Shipping Conditions
Shipped in Dry Ice
Technology
TR-FRET
Therapeutic Area
Inflammation
Neuroscience
Oncology & Inflammation
Unit Size
1 unit

Video gallery

HTRF Thalidomide Red Ligand
HTRF Thalidomide Red Ligand

Resources

Are you looking for resources, click on the resource type to explore further.

  • - すべて -:-:- Any -
  • Guide:-:2
  • Technical Note:-:1
1-1 of 1 Resources
Technical Note Icon
Technical Note
How to access true Kd values in Protein-Protein Interaction assays

Investigate the dynamics of Interactions

Kinetic values are of importance for characterizing protein-protein interactions...

Learn more

How can we help you?

We are here to answer your questions.

Contact sales I would like more product information Contact customer care Get technical support
Get Help Illustration Get Help Illustration
Scroll Icon
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.